4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-018271
President and CEO gave up 5,343 shares (to pay taxes)
- President and CEO acquired 15,450 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Culley Brian M President and CEO | 2022-06-30 | Option exercise | +15,450 | 113,237 | D | ||
| Culley Brian M President and CEO | 2022-06-30 | Shares withheld for taxes | −5,343 | $1.58 | $8,442 | 107,894 | D |
| Derivatives | |||||||
| Culley Brian M President and CEO | 2022-06-30 | Option exercise · Restricted Stock Units | −15,450 | 0 | D | ||
Loading xslF345X03/ownership.xml…